Insiders AbbVie Inc.

Equities

ABBV

US00287Y1091

Pharmaceuticals

Market Closed - Nyse Other stock markets 21:00:03 13/05/2026 BST			5-day change	1st Jan Change
208.50 ^USD	+0.31%		+1.69%	-8.75%

10:48am	Piper Sandler Adjusts Price Target on AbbVie to $298 From $294, Maintains Overweight Rating	MT
05-13	AbbVie Inc. Presents at Bank of America Global Healthcare Conference 2026, May-13-2026 11:20 AM

Insiders

13/05/25	Abbvie Inc - Expands Board To 15 Directors, Appoints Thomas J. Falk - SEC Filing	RE
13/05/25	Abbvie Inc. Appoints Thomas J. Falk as A Class III Director on May 9, 2025	CI
18/03/25	Abbvie Insider Sold Shares Worth $3,746,527, According to a Recent SEC Filing	MT
14/02/25	Correction to AbbVie Names CEO Robert Michael Chairman Article	DJ
14/02/25	AbbVie Names CEO Robert Michael Chairman as Richard Gonzales Retires	DJ
14/02/25	AbbVie CEO Robert Michael to Succeed Richard Gonzalez as Chair	MT
14/02/25	AbbVie Names CEO Robert Michael as Chairman, Effective July 1	MT
14/02/25	AbbVie Inc. Announces Board Changes, Effective July 1, 2025	CI
14/02/25	Abbvie Elects Robert A. Michael As Chairman	RE
10/07/24	Abbvie Announces Appointment of Roopal Thakkar as Executive Vice President, Research & Development and Chief Scientific Officer	CI
01/07/24	AbbVie: new CEO takes up post
01/07/24	AbbVie Says Robert Michael Assumes CEO Role	MT
01/07/24	AbbVie Announces Board Changes	CI
20/06/24	AbbVie Inc. Announces Board of Directors Changes	CI
26/04/24	Abbvie Inc. Announces Board Changes, Effective July 1, 2024	CI
22/03/24	Abbvie Insider Sold Shares Worth $3,716,757, According to a Recent SEC Filing	MT
21/03/24	Abbvie Insider Sold Shares Worth $10,539,508, According to a Recent SEC Filing	MT
01/03/24	Abbvie Insider Sold Shares Worth $1,754,555, According to a Recent SEC Filing	MT
01/03/24	Abbvie Insider Sold Shares Worth $12,153,957, According to a Recent SEC Filing	MT
01/03/24	Abbvie Insider Sold Shares Worth $908,688, According to a Recent SEC Filing	MT
01/03/24	Abbvie Insider Sold Shares Worth $2,509,002, According to a Recent SEC Filing	MT
23/02/24	Abbvie Insider Sold Shares Worth $9,184,048, According to a Recent SEC Filing	MT
20/02/24	AbbVie CEO to Retire; COO Robert Michael Named Successor	MT
20/02/24	AbbVie Names Robert Michael CEO, Richard Gonzalez Executive Chair	MT
20/02/24	AbbVie Names Robert Michael to Succeed Richard Gonzalez as CEO	DJ